婴儿无晶状体治疗研究 (IATS) (IATS)
研究概览
详细说明
人工晶状体现在是治疗大龄儿童白内障的一种普遍接受的治疗方法,并且越来越多地用于年幼的儿童和婴儿。 人工晶状体优于隐形眼镜,因为它们更接近晶状体的光学特性,不需要日常护理,并且始终确保至少部分光学矫正。 人工晶状体矫正的简单性和改善的视力结果可以减轻父母照顾患有单侧先天性白内障的儿童的压力。 然而,由于担心人工晶状体的长期安全性以及这些眼睛在成长过程中可能出现较大的近视偏移,隐形眼镜仍然是 1 岁以下儿童可接受的治疗方法。 隐形眼镜为接受双侧先天性白内障治疗的婴儿提供了极好的视觉效果;然而,接受单侧先天性白内障隐形眼镜治疗的婴儿中,有三分之二的无晶状体眼在法律上仍然失明。 这些不良的视力结果通常归因于来自健全眼睛的竞争以及对修补和隐形眼镜佩戴方案的依从性差。 我们的试点研究数据和文献表明,如果在婴儿期使用人工晶状体矫正单侧无晶状体可以获得更好的视觉效果,但这些眼睛会出现更多并发症。 无论我们是否进行这项试验,婴儿植入人工晶状体的人数将越来越多。 通过进行这项临床试验,我们可以确定人工晶状体较高的并发症发生率是否被改善的视力结果和减轻的育儿压力所抵消。
婴儿无晶状体治疗研究 (IATS) 是一项多中心随机临床试验,比较人工晶状体和隐形眼镜矫正单眼无晶状体的效果。 婴儿将在 4 年内注册。 28 至 210 天大的一只眼睛患有视觉上明显的白内障的婴儿符合条件。 白内障手术将由获得研究认证的外科医生以标准化方式进行。 手术包括晶状体切除术、后囊切开术和前玻璃体切除术。 婴儿将在手术时随机分配到两个治疗组之一。 随机分配到人工晶状体组的婴儿将在囊袋中植入人工晶状体。 随后将使用眼镜来矫正残留的屈光不正。 随机分配到隐形眼镜组的婴儿将在手术后立即配戴隐形眼镜。 两组都将接受相同的修补疗法和随访。 研究人员将使用标准方案定期对所有儿童进行检查,主要终点由旅行视力检查员在 12 个月大时进行评估。
我们目前正在继续这个项目(超过 5 年),以评估这些患者中有哪些在 10.5 岁时患有青光眼或疑似青光眼。 我们的目标是了解在婴儿期单侧先天性白内障手术后,哪种类型的初始光学矫正(IOL 或 CL)可以产生最佳的长期视力结果。 我们的中心假设是初次植入 IOL 会带来更好的视觉效果。 该提议的基本原理是最终视力不能在 5 岁时确定,早期治疗的建议只能通过对该独特队列进行充分的长期评估来证实。 我们选择了 10.5 岁的随访,因为它将提供更准确的视力评估,并使我们能够诊断大多数青光眼病例。
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
California
-
Palo Alto、California、美国、94303
- Stanford University
-
-
Florida
-
Miami、Florida、美国、33155
- Miami Children's Hospital
-
-
Georgia
-
Atlanta、Georgia、美国、30322
- Emory Eye Center
-
-
Indiana
-
Indianapolis、Indiana、美国、46202-5175
- Indiana University Medical Center
-
-
Massachusetts
-
Boston、Massachusetts、美国、02115
- Harvard University
-
-
Minnesota
-
Minneapolis、Minnesota、美国、55455-0501
- University of Minnesota
-
-
North Carolina
-
Durham、North Carolina、美国、27710
- Duke University Eye Center
-
-
Ohio
-
Cleveland、Ohio、美国、44195
- Cleveland Clinic Foundation
-
-
Oregon
-
Portland、Oregon、美国、97239-4197
- Oregon Health and Science University
-
-
South Carolina
-
Charleston、South Carolina、美国、29425-2236
- Medical University of South Carolina
-
-
Tennessee
-
Nashville、Tennessee、美国、37232-8808
- Vanderbilt University
-
-
Texas
-
Dallas、Texas、美国、75225
- Pediatric Ophthalmology, P.A.
-
Houston、Texas、美国、77030
- Baylor University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
描述
纳入标准:
- 视觉上显着的单侧先天性白内障(中心不透明度等于或大于 3 毫米)。
- 当患者 28 至 210 天大且至少受孕后 41 周时进行白内障手术。
排除标准:
- 已知白内障是从外伤中获得的,或者是产后进行的治疗(例如放射或药物治疗)的副作用。
- 使用卡尺在水平子午线上测量的角膜直径小于 9 毫米。
- 使用 Perkins 眼压计、眼压计或气压计测量的受影响眼睛的眼内压为 25 毫米汞柱或更高。
- 持续性胎儿血管系统 (PFV) 导致睫状突拉伸或牵拉性视网膜脱离。
- 活动性葡萄膜炎或提示先前葡萄膜炎发作的迹象,例如后粘连或角质沉淀物。
- 孩子是早产(<36 孕周)的产物。 早产筛查将基于临床医生对孕龄的最佳评估。 如果医生不确定胎龄,应通过查阅医疗记录或联系儿科医生和/或产科医生来确认分娩时的胎龄。 除非临床医生不确定孩子是否出生时不足 36 周,否则通过病历审查确认胎龄可能会延迟到入组后。
- 可能限制眼睛视觉潜能的视网膜疾病,例如早产儿视网膜病变。
- 以前的眼内手术。
- 可能限制眼睛视觉潜能的视神经疾病,例如视神经发育不全。
- 另一只眼睛患有可能会降低其视力潜能的眼部疾病。
- 孩子的身体状况已知会限制在 12 个月或 4 岁时获得视力的能力。
- 父母/法定监护人拒绝签署知情同意书或拒绝随机分配到两个治疗组之一。
- 对孩子进行随访是不可行的,因为孩子将无法返回进行定期随访检查和结果评估(例如交通困难、搬迁等)。
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:无晶状体隐形眼镜
无晶状体隐形眼镜矫正 干预:使用外部隐形眼镜 (CL) 来矫正因手术摘除天然白内障晶状体而产生的较大远视屈光不正。 随着眼睛的长大,屈光不正发生变化,CL 的屈光力也随之改变。 |
接触镜光学矫正婴幼儿手术无晶状体
其他名称:
|
|
实验性的:无晶状体人工晶状体
人工晶状体植入术 干预:在手术切除白内障天然晶状体时,植入人工晶状体以矫正白内障手术引起的大远视屈光不正。 |
人工晶状体手术无晶状体的光学矫正
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
视力
大体时间:第一阶段 - 12 个月大
|
在 12 个月大时通过标准客观测试程序测量视力。
单眼光栅敏锐度由巡回检查员使用 Teller Acuity Cards 评估。
此测试使用的卡片具有不同宽度的黑白线条,并且在固定尺寸的正方形中间隔一定距离,因此线条越细,任何给定卡片上的线条越多(周期/厘米)。
能够看到更细的线条表明视力更好。
带有线条的卡片与灰色卡片同时呈现,并记录孩子的视觉注意力。
据推测,孩子会优先看带有条纹的卡片,因为它更有趣。
当线条太细且靠得太近以至于与灰卡无法区分时,将不会注意到优先查找。
孩子将要看的线条最细的卡片被记录为以 logMAR 为单位的最佳视力。
|
第一阶段 - 12 个月大
|
|
视力 - 4.5 岁时的主观评估。
大体时间:第 2 阶段 - 4.5 岁
|
通过在每个临床站点使用电子视力测试仪 (EVAT) 对视力估计进行标准化。
IATS 患者在 4.5 岁时接受测试,允许使用 HOTV 识别敏锐度测试。
遵循用于呈现和确定最佳矫正视力的弱视治疗研究方案。
使用单字母视标评估单眼视力,并在 EVAT 上显示环绕条。
遵循 ATS 项目的阶梯程序,因为这已记录了该年龄组的成功和可靠性。
为了使受试者熟悉 HOTV 匹配测试,在 4.0 年访问和 4.25 年访问时由经验丰富的现场人员引入此测试。
|
第 2 阶段 - 4.5 岁
|
|
视力 - 10 岁时的主观评估。
大体时间:第 3 阶段 - 10.5 岁
|
通过在每个临床站点使用电子视力测试仪 (EVAT) 对视力估计进行标准化。
IATS 患者在 10.5 岁时接受了测试,允许使用电子早期治疗糖尿病视网膜病变研究 (E-ETDRS) 测试协议。
LogMAR 的范围通常为 -0.3(Snellen 图表上的 20/10 视力)到 1(20/200 视力)。
|
第 3 阶段 - 10.5 岁
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
在白内障手术中出现 1 种或多种术中并发症的患者百分比
大体时间:入学后立即进行白内障手术
|
在白内障手术中出现 1 种或多种术中并发症的患者百分比
|
入学后立即进行白内障手术
|
|
发生 1 种或多种不良事件的患者百分比
大体时间:学习入学至 5 岁
|
学习入学至 5 岁
|
|
|
育儿压力
大体时间:阶段 1 - 手术后 3 个月
|
PSI 是一个 120 项经过验证的育儿压力自我报告测量方法。
PSI 是一种测量压力的连续刻度,范围为 131(低压力)至 320(高压力);一般人的压力分数在 188 到 252 之间。
|
阶段 1 - 手术后 3 个月
|
|
坚持闭塞治疗
大体时间:第 1 阶段 - 12 个月的后续行动
|
父母报告孩子佩戴眼罩遮挡对侧眼的小时数。
|
第 1 阶段 - 12 个月的后续行动
|
|
育儿压力
大体时间:第一阶段 - 12 个月大
|
PSI 是一个 120 项经过验证的育儿压力自我报告测量方法。
PSI 是一种测量压力的连续刻度,范围为 131(低压力)至 320(高压力);普通人的压力分数在 188 到 252 之间
|
第一阶段 - 12 个月大
|
合作者和调查者
合作者
调查人员
- 学习椅:Scott Lambert, MD、Stanford University
出版物和有用的链接
一般刊物
- Bothun ED, Lynn MJ, Lambert SR. Author reply: To PMID 23419803. Ophthalmology. 2014 Oct;121(10):e53. doi: 10.1016/j.ophtha.2014.05.011. Epub 2014 Jun 6. No abstract available.
- Traboulsi EI, Vanderveen D, Morrison D, Drews-Botsch CD, Lambert SR; Infant Aphakia Treatment Study Group. Associated systemic and ocular disorders in patients with congenital unilateral cataracts: the Infant Aphakia Treatment Study experience. Eye (Lond). 2016 Sep;30(9):1170-4. doi: 10.1038/eye.2016.124. Epub 2016 Jun 17.
- Drews-Botsch C, Celano M, Cotsonis G, Hartmann EE, Lambert SR; Infant Aphakia Treatment Study Group. Association Between Occlusion Therapy and Optotype Visual Acuity in Children Using Data From the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2016 Aug 1;134(8):863-9. doi: 10.1001/jamaophthalmol.2016.1365.
- Lambert SR, Plager DA, Lynn MJ, Wilson ME. Visual outcome following the reduction or cessation of patching therapy after early unilateral cataract surgery. Arch Ophthalmol. 2008 Aug;126(8):1071-4. doi: 10.1001/archopht.126.8.1071.
- Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR; Infant Aphakia Treatment Study Group. Complications, adverse events, and additional intraocular surgery 1 year after cataract surgery in the infant Aphakia Treatment Study. Ophthalmology. 2011 Dec;118(12):2330-4. doi: 10.1016/j.ophtha.2011.06.017. Epub 2011 Sep 16.
- Morrison DG, Wilson ME, Trivedi RH, Lambert SR, Lynn MJ; Infant Aphakia Treatment Study Group. Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age. J AAPOS. 2011 Oct;15(5):427-31. doi: 10.1016/j.jaapos.2011.06.004.
- Wilson ME, Trivedi RH, Morrison DG, Lambert SR, Buckley EG, Plager DA, Lynn MJ; Infant Aphakia Treatment Study Group. The Infant Aphakia Treatment Study: evaluation of cataract morphology in eyes with monocular cataracts. J AAPOS. 2011 Oct;15(5):421-6. doi: 10.1016/j.jaapos.2011.05.016.
- Drews-Botsch CD, Hartmann EE, Celano M; Infant Aphakia Treatment Study Group. Predictors of adherence to occlusion therapy 3 months after cataract extraction in the Infant Aphakia Treatment Study. J AAPOS. 2012 Apr;16(2):150-5. doi: 10.1016/j.jaapos.2011.12.149.
- Beck AD, Freedman SF, Lynn MJ, Bothun E, Neely DE, Lambert SR; Infant Aphakia Treatment Study Group. Glaucoma-related adverse events in the Infant Aphakia Treatment Study: 1-year results. Arch Ophthalmol. 2012 Mar;130(3):300-5. doi: 10.1001/archophthalmol.2011.347. Epub 2011 Nov 14.
- VanderVeen DK, Nizam A, Lynn MJ, Bothun ED, McClatchey SK, Weakley DR, DuBois LG, Lambert SR; Infant Aphakia Treatment Study Group. Predictability of intraocular lens calculation and early refractive status: the Infant Aphakia Treatment Study. Arch Ophthalmol. 2012 Mar;130(3):293-9. doi: 10.1001/archophthalmol.2011.358.
- Russell B, Ward MA, Lynn M, Dubois L, Lambert SR; Infant Aphakia Treatment Study Group. The infant aphakia treatment study contact lens experience: one-year outcomes. Eye Contact Lens. 2012 Jul;38(4):234-9. doi: 10.1097/ICL.0b013e3182562dc0.
- Lambert SR, Purohit A, Superak HM, Lynn MJ, Beck AD. Long-term risk of glaucoma after congenital cataract surgery. Am J Ophthalmol. 2013 Aug;156(2):355-361.e2. doi: 10.1016/j.ajo.2013.03.013. Epub 2013 Apr 30.
- Carrigan AK, DuBois LG, Becker ER, Lambert SR; Infant Aphakia Treatment Study Group. Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery: retrospective analysis at age 1 year. Ophthalmology. 2013 Jan;120(1):14-9. doi: 10.1016/j.ophtha.2012.07.049. Epub 2012 Oct 6.
- Trivedi RH, Lambert SR, Lynn MJ, Wilson ME; Infant Aphakia Treatment Study Group. The role of preoperative biometry in selecting initial contact lens power in the Infant Aphakia Treatment Study. J AAPOS. 2014 Jun;18(3):251-4. doi: 10.1016/j.jaapos.2014.01.012.
- Vanderveen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR; Infant Aphakia Treatment Study Group. Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the Infant Aphakia Treatment Study. Am J Ophthalmol. 2013 Dec;156(6):1252-1260.e2. doi: 10.1016/j.ajo.2013.07.014. Epub 2013 Sep 4.
- Hartmann EE, Stout AU, Lynn MJ, Yen KG, Kruger SJ, Lambert SR; Infant Aphakia Treatment Study Group; Infant Aphakia Treatment Study Group. Stereopsis results at 4.5 years of age in the infant aphakia treatment study. Am J Ophthalmol. 2015 Jan;159(1):64-70.e1-2. doi: 10.1016/j.ajo.2014.09.028. Epub 2014 Sep 28.
- Kruger SJ, DuBois L, Becker ER, Morrison D, Wilson L, Wilson ME Jr, Lambert SR; Infant Aphakia Treatment Study Group. Cost of intraocular lens versus contact lens treatment after unilateral congenital cataract surgery in the infant aphakia treatment study at age 5 years. Ophthalmology. 2015 Feb;122(2):288-92. doi: 10.1016/j.ophtha.2014.08.037. Epub 2014 Oct 29.
- Wall PB, Lee JA, Lynn MJ, Lambert SR, Traboulsi EI; Infant Aphakia Treatment Study Group. The effects of surgical factors on postoperative astigmatism in patients enrolled in the Infant Aphakia Treatment Study (IATS). J AAPOS. 2014 Oct;18(5):441-5. doi: 10.1016/j.jaapos.2014.06.016. Epub 2014 Sep 27.
- Bothun ED, Cleveland J, Lynn MJ, Christiansen SP, Vanderveen DK, Neely DE, Kruger SJ, Lambert SR; Infant Aphakic Treatment Study. One-year strabismus outcomes in the Infant Aphakia Treatment Study. Ophthalmology. 2013 Jun;120(6):1227-31. doi: 10.1016/j.ophtha.2012.11.039. Epub 2013 Feb 16.
- Freedman SF, Lynn MJ, Beck AD, Bothun ED, Orge FH, Lambert SR; Infant Aphakia Treatment Study Group. Glaucoma-Related Adverse Events in the First 5 Years After Unilateral Cataract Removal in the Infant Aphakia Treatment Study. JAMA Ophthalmol. 2015 Aug;133(8):907-14. doi: 10.1001/jamaophthalmol.2015.1329.
- Plager DA, Lynn MJ, Buckley EG, Wilson ME, Lambert SR; Infant Aphakia Treatment Study Group. Complications in the first 5 years following cataract surgery in infants with and without intraocular lens implantation in the Infant Aphakia Treatment Study. Am J Ophthalmol. 2014 Nov;158(5):892-8. doi: 10.1016/j.ajo.2014.07.031. Epub 2014 Jul 29.
- Morrison DG, Lynn MJ, Freedman SF, Orge FH, Lambert SR; Infant Aphakia Treatment Study Group. Corneal Changes in Children after Unilateral Cataract Surgery in the Infant Aphakia Treatment Study. Ophthalmology. 2015 Nov;122(11):2186-92. doi: 10.1016/j.ophtha.2015.07.011. Epub 2015 Aug 11.
- VanderVeen DK, Trivedi RH, Nizam A, Lynn MJ, Lambert SR. Reply: To PMID 24011524. Am J Ophthalmol. 2014 Jun;157(6):1332-3. doi: 10.1016/j.ajo.2014.02.053. No abstract available.
- Kumar P, Lambert SR. Evaluating the evidence for and against the use of IOLs in infants and young children. Expert Rev Med Devices. 2016;13(4):381-9. doi: 10.1586/17434440.2016.1153967. Epub 2016 Feb 29.
- Bothun ED, Lynn MJ, Christiansen SP, Neely DE, Vanderveen DK, Kruger SJ, Lambert SR; Infant Aphakia Treatment Study. Sensorimotor outcomes by age 5 years after monocular cataract surgery in the Infant Aphakia Treatment Study (IATS). J AAPOS. 2016 Feb;20(1):49-53. doi: 10.1016/j.jaapos.2015.11.002.
- Celano M, Hartmann EE, DuBois LG, Drews-Botsch C; Infant Aphakia Treatment Study Group. Motor skills of children with unilateral visual impairment in the Infant Aphakia Treatment Study. Dev Med Child Neurol. 2016 Feb;58(2):154-9. doi: 10.1111/dmcn.12832. Epub 2015 Jun 17.
- Lambert SR, Plager DA, Buckley EG, Wilson ME, DuBois L, Drews-Botsch CD, Hartmann EE, Lynn MJ; Infant Aphakia Treatment Study Group. The Infant Aphakia Treatment Study: further on intra- and postoperative complications in the intraocular lens group. J AAPOS. 2015 Apr;19(2):101-3. doi: 10.1016/j.jaapos.2015.01.012. No abstract available.
- Lambert SR, Lynn MJ, Hartmann EE; Infant Aphakia Treatment Study Group. In reply. JAMA Ophthalmol. 2014 Dec;132(12):1492-3. doi: 10.1001/jamaophthalmol.2014.3542. No abstract available.
- Celano M, Hartmann EE, Drews-Botsch CD; Infant Aphakia Treatment Study Group. Parenting stress in the infant aphakia treatment study. J Pediatr Psychol. 2013 Jun;38(5):484-93. doi: 10.1093/jpepsy/jst009. Epub 2013 Mar 9.
- Lenhart PD, Courtright P, Wilson ME, Lewallen S, Taylor DS, Ventura MC, Bowman R, Woodward L, Ditta LC, Kruger S, Haddad D, El Shakankiri N, Rai SK, Bailey T, Lambert SR. Global challenges in the management of congenital cataract: proceedings of the 4th International Congenital Cataract Symposium held on March 7, 2014, New York, New York. J AAPOS. 2015 Apr;19(2):e1-8. doi: 10.1016/j.jaapos.2015.01.013.
- Nguyen M, Shainberg M, Beck AD, Lambert SR. Structural changes of the anterior chamber following cataract surgery during infancy. J Cataract Refract Surg. 2015 Aug;41(8):1784-6. doi: 10.1016/j.jcrs.2015.07.001. No abstract available.
- Russell B, DuBois L, Lynn M, Ward MA, Lambert SR; Infant Aphakia Treatment Study Group. The Infant Aphakia Treatment Study Contact Lens Experience to Age 5 Years. Eye Contact Lens. 2017 Nov;43(6):352-357. doi: 10.1097/ICL.0000000000000291.
- Lambert SR. The timing of surgery for congenital cataracts: Minimizing the risk of glaucoma following cataract surgery while optimizing the visual outcome. J AAPOS. 2016 Jun;20(3):191-2. doi: 10.1016/j.jaapos.2016.04.003. Epub 2016 May 11. No abstract available.
- Celano M, Cotsonis GA, Hartmann EE, Drews-Botsch C; Infant Aphakia Treatment Study Group. Behaviors of children with unilateral vision impairment in the Infant Aphakia Treatment Study. J AAPOS. 2016 Aug;20(4):320-5. doi: 10.1016/j.jaapos.2016.04.008. Epub 2016 Jul 14.
- Drews-Botsch C, Cotsonis G, Celano M, Lambert SR. Assessment of Adherence to Visual Correction and Occlusion Therapy in the Infant Aphakia Treatment Study. Contemp Clin Trials Commun. 2016 Aug 15;3:158-166. doi: 10.1016/j.conctc.2016.05.009. Epub 2016 May 30.
- Lambert SR, DuBois L, Cotsonis G, Hartmann EE, Drews-Botsch C. Factors associated with stereopsis and a good visual acuity outcome among children in the Infant Aphakia Treatment Study. Eye (Lond). 2016 Sep;30(9):1221-8. doi: 10.1038/eye.2016.164. Epub 2016 Jul 29.
- Bothun ED, Lynn MJ, Christiansen SP, Kruger SJ, Vanderveen DK, Neely DE, Lambert SR; Infant Aphakic Treatment Study. Strabismus surgery outcomes in the Infant Aphakia Treatment Study (IATS) at age 5 years. J AAPOS. 2016 Dec;20(6):501-505. doi: 10.1016/j.jaapos.2016.09.014. Epub 2016 Nov 2.
- Lambert SR, Cotsonis G, DuBois L, Wilson ME, Plager DA, Buckley EG, McClatchey SK; Infant Aphakia Treatment Study Group. Comparison of the rate of refractive growth in aphakic eyes versus pseudophakic eyes in the Infant Aphakia Treatment Study. J Cataract Refract Surg. 2016 Dec;42(12):1768-1773. doi: 10.1016/j.jcrs.2016.09.021.
- Cooke DL. Predictability of intraocular lens power calculation formulae in infantile eyes with unilateral congenital cataract: results from the infant aphakia treatment study. Am J Ophthalmol. 2014 Jun;157(6):1332. doi: 10.1016/j.ajo.2014.02.051. No abstract available.
- Drews-Botsch CD, Celano M, Kruger S, Hartmann EE; Infant Aphakia Treatment Study. Adherence to occlusion therapy in the first six months of follow-up and visual acuity among participants in the Infant Aphakia Treatment Study (IATS). Invest Ophthalmol Vis Sci. 2012 Jun 5;53(7):3368-75. doi: 10.1167/iovs.11-8457.
- Felius J, Busettini C, Lynn MJ, Hartmann EE, Lambert SR; Infant Aphakia Treatment Study Group. Nystagmus and related fixation instabilities following extraction of unilateral infantile cataract in the Infant Aphakia Treatment Study (IATS). Invest Ophthalmol Vis Sci. 2014 Aug 5;55(8):5332-7. doi: 10.1167/iovs.14-14710.
- Lambert SR, Lynn MJ, DuBois LG, Cotsonis GA, Hartmann EE, Wilson ME; Infant Aphakia Treatment Study Groups. Axial elongation following cataract surgery during the first year of life in the infant Aphakia Treatment Study. Invest Ophthalmol Vis Sci. 2012 Nov 7;53(12):7539-45. doi: 10.1167/iovs.12-10285.
- Wilson ME, Trivedi RH, Weakley DR Jr, Cotsonis GA, Lambert SR; Infant Aphakia Treatment Study Group. Globe Axial Length Growth at Age 5 Years in the Infant Aphakia Treatment Study. Ophthalmology. 2017 May;124(5):730-733. doi: 10.1016/j.ophtha.2017.01.010. Epub 2017 Feb 10.
- Weakley DR Jr, Lynn MJ, Dubois L, Cotsonis G, Wilson ME, Buckley EG, Plager DA, Lambert SR; Infant Aphakia Treatment Study Group. Myopic Shift 5 Years after Intraocular Lens Implantation in the Infant Aphakia Treatment Study. Ophthalmology. 2017 Jun;124(6):822-827. doi: 10.1016/j.ophtha.2016.12.040. Epub 2017 Feb 16.
- Plager DA, Lynn MJ, Lambert SR, Buckley EG, Wilson ME; Infant Aphakia Treatment Study Group. Reply: To PMID 25077835. Am J Ophthalmol. 2014 Dec;158(6):1361-2. doi: 10.1016/j.ajo.2014.09.019. Epub 2014 Nov 18. No abstract available.
- Weakley D, Cotsonis G, Wilson ME, Plager DA, Buckley EG, Lambert SR; Infant Aphakia Treatment Study Group. Anisometropia at Age 5 Years After Unilateral Intraocular Lens Implantation During Infancy in the Infant Aphakia Treatment Study. Am J Ophthalmol. 2017 Aug;180:1-7. doi: 10.1016/j.ajo.2017.05.008. Epub 2017 May 17.
- Traboulsi EI, Freedman SF, Wilson ME Jr, Lambert SR; Infant Aphakia Treatment Study Group. Cataract morphology and risk for glaucoma after cataract surgery in infants with unilateral congenital cataract. J Cataract Refract Surg. 2017 Dec;43(12):1611-1612. doi: 10.1016/j.jcrs.2017.10.032. No abstract available.
- Koo EB, VanderVeen DK, Lambert SR. Global Practice Patterns in the Management of Infantile Cataracts. Eye Contact Lens. 2018 Nov;44 Suppl 2(Suppl 2):S292-S296. doi: 10.1097/ICL.0000000000000461.
- Cromelin CH, Drews-Botsch C, Russell B, Lambert SR; Infant Aphakia Treatment Study Group. Association of Contact Lens Adherence With Visual Outcome in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2018 Mar 1;136(3):279-285. doi: 10.1001/jamaophthalmol.2017.6691.
- Weakley DR Jr, Lynn MJ, Dubois L, Cotsonis G, Wilson ME, Buckley EG, Plager DA, Lambert SR; Infant Aphakia Treatment Study Group. Reply. Ophthalmology. 2018 Oct;125(10):e69-e70. doi: 10.1016/j.ophtha.2018.03.058. No abstract available.
- Hartmann EE, Drews-Botsch C, DuBois LG, Cotsonis G, Lambert SR; Infant Aphakia Treatment Study Group. Correlation of monocular grating acuity at age 12 months with recognition acuity at age 4.5 years: findings from the Infant Aphakia Treatment Study. J AAPOS. 2018 Aug;22(4):299-303.e2. doi: 10.1016/j.jaapos.2018.03.011. Epub 2018 Jul 20.
- Lambert SR, DuBois L, Cotsonis G, Hartmann EE, Drews-Botsch C; Infant Aphakia Treatment Study Group. Spectacle Adherence Among Four-Year-Old Children in the Infant Aphakia Treatment Study. Am J Ophthalmol. 2019 Apr;200:26-33. doi: 10.1016/j.ajo.2018.12.017. Epub 2019 Jan 8.
- Drews-Botsch C, Celano M, Cotsonis G, DuBois L, Lambert SR; Infant Aphakia Treatment Study Group. Parenting Stress and Adherence to Occlusion Therapy in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. Transl Vis Sci Technol. 2019 Jan 2;8(1):3. doi: 10.1167/tvst.8.1.3. eCollection 2019 Jan.
- Lambert SR, Bothun ED, Plager DA. Five-Year Postoperative Outcomes of Bilateral Aphakia and Pseudophakia in Children up to 2 Years of Age: A Randomized Clinical Trial. Am J Ophthalmol. 2019 Mar;199:263-264. doi: 10.1016/j.ajo.2018.09.042. Epub 2018 Dec 19. No abstract available.
- Kruger SJ, Vanderveen DK, Freedman SF, Bothun E, Drews-Botsch CD, Lambert SR; Infant Aphakia Study Group. Third-Party Coverage for Aphakic Contact Lenses for Children. Transl Vis Sci Technol. 2019 Jun 14;8(3):41. doi: 10.1167/tvst.8.3.41. eCollection 2019 May. No abstract available.
- Lambert SR, Cotsonis G, DuBois L, Nizam Ms A, Kruger SJ, Hartmann EE, Weakley DR Jr, Drews-Botsch C; Infant Aphakia Treatment Study Group. Long-term Effect of Intraocular Lens vs Contact Lens Correction on Visual Acuity After Cataract Surgery During Infancy: A Randomized Clinical Trial. JAMA Ophthalmol. 2020 Apr 1;138(4):365-372. doi: 10.1001/jamaophthalmol.2020.0006.
- Lambert SR, Nizam A, DuBois L, Cotsonis G, Weakley DR Jr, Wilson ME; Infant Aphakia Treatment Study Group. The Myopic Shift in Aphakic Eyes in the Infant Aphakia Treatment Study After 10 Years of Follow-up. Eye Contact Lens. 2021 Feb 1;47(2):108-112. doi: 10.1097/ICL.0000000000000718.
- Plager DA, Bothun ED, Freedman SF, Wilson ME, Lambert SR. Complications at 10 Years of Follow-up in the Infant Aphakia Treatment Study. Ophthalmology. 2020 Nov;127(11):1581-1583. doi: 10.1016/j.ophtha.2020.04.046. Epub 2020 May 11. No abstract available.
- Traboulsi EI, Drews-Botsch CD, Christiansen SP, Stout AU, Hartmann EE, Lambert SR; IATS Investigator Group. Rate of ocular trauma in children operated on for unilateral cataract in infancy-data from the Infant Aphakia Treatment Study. J AAPOS. 2020 Oct;24(5):301-303. doi: 10.1016/j.jaapos.2020.06.005. Epub 2020 Aug 31.
- VanderVeen DK, Drews-Botsch CD, Nizam A, Bothun ED, Wilson LB, Wilson ME, Lambert SR; Infant Aphakia Treatment Study. Outcomes of secondary intraocular lens implantation in the Infant Aphakia Treatment Study. J Cataract Refract Surg. 2021 Feb 1;47(2):172-177. doi: 10.1097/j.jcrs.0000000000000412.
- McClatchey SK, McClatchey TS, Cotsonis G, Nizam A, Lambert SR; Infant Aphakia Treatment Study Group. Refractive growth variability in the Infant Aphakia Treatment Study. J Cataract Refract Surg. 2021 Apr 1;47(4):512-515. doi: 10.1097/j.jcrs.0000000000000482.
- Freedman SF, Beck AD, Nizam A, Vanderveen DK, Plager DA, Morrison DG, Drews-Botsch CD, Lambert SR; Infant Aphakia Treatment Study Group. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 Feb 1;139(2):165-173. doi: 10.1001/jamaophthalmol.2020.5664.
- Weakley DR Jr, Nizam A, VanderVeen DK, Wilson ME, Kruger S, Lambert SR; Infant Aphakia Treatment Study Group. Myopic Shift at 10-Year Follow-up in the Infant Aphakia Treatment Study. Ophthalmology. 2022 Sep;129(9):1064-1065. doi: 10.1016/j.ophtha.2022.04.004. Epub 2022 Apr 8.
- Oke I, VanderVeen DK, McClatchey TS, Lambert SR, McClatchey SK; Infant Aphakia Treatment Study Group. The accuracy of intraocular lens calculation varies by age in the Infant Aphakia Treatment Study. J AAPOS. 2022 Jun;26(3):143-145. doi: 10.1016/j.jaapos.2022.02.004. Epub 2022 May 6.
- Bothun ED, Shainberg MJ, Christiansen SP, Vanderveen DK, Neely DE, Kruger SJ, Cotsonis G, Lambert SR; Infant Aphakic Treatment Study. Long-term strabismus outcomes after unilateral infantile cataract surgery in the Infant Aphakia Treatment Study. J AAPOS. 2022 Aug;26(4):174.e1-174.e4. doi: 10.1016/j.jaapos.2022.05.003. Epub 2022 Jul 14.
- Hartmann EE, Lynn MJ, Lambert SR; Infant Aphakia Treatment Study Group. Baseline characteristics of the infant aphakia treatment study population: predicting recognition acuity at 4.5 years of age. Invest Ophthalmol Vis Sci. 2014 Dec 11;56(1):388-95. doi: 10.1167/iovs.14-15464.
- Infant Aphakia Treatment Study Group; Lambert SR, Buckley EG, Drews-Botsch C, DuBois L, Hartmann E, Lynn MJ, Plager DA, Wilson ME. The infant aphakia treatment study: design and clinical measures at enrollment. Arch Ophthalmol. 2010 Jan;128(1):21-7. doi: 10.1001/archophthalmol.2009.350.
- Infant Aphakia Treatment Study Group; Lambert SR, Buckley EG, Drews-Botsch C, DuBois L, Hartmann EE, Lynn MJ, Plager DA, Wilson ME. A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: grating acuity and adverse events at age 1 year. Arch Ophthalmol. 2010 Jul;128(7):810-8. doi: 10.1001/archophthalmol.2010.101. Epub 2010 May 10.
- Infant Aphakia Treatment Study Group; Lambert SR, Lynn MJ, Hartmann EE, DuBois L, Drews-Botsch C, Freedman SF, Plager DA, Buckley EG, Wilson ME. Comparison of contact lens and intraocular lens correction of monocular aphakia during infancy: a randomized clinical trial of HOTV optotype acuity at age 4.5 years and clinical findings at age 5 years. JAMA Ophthalmol. 2014 Jun;132(6):676-82. doi: 10.1001/jamaophthalmol.2014.531.
- Drews-Botsch C, Cotsonis G, Celano M, Hartmann EE, Zaidi J, Lambert SR. Patching in Children With Unilateral Congenital Cataract and Child Functioning and Parenting Stress. JAMA Ophthalmol. 2024 Jun 1;142(6):503-510. doi: 10.1001/jamaophthalmol.2024.0800.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.